My colleagues and I read with the greatest attention the letter by Dr Jobanputra. Dr Jobanputra is correct in stating that some of the authors were involved in one of the key trials1 cited in our systematic review.2 However, some points that justify why we did not declare any conflict of interests relevant to this article should be clarified.
Reginster J. Structural and Symptomatic Efficacy of Glucosamine and Chondroitin: Relevant Financial Interest?—Reply. Arch Intern Med. 2004;164(3):339. doi:10.1001/archinte.164.3.339-a